RoboCT was founded in 2017. As a high-tech enterprise specializing in robotic exoskeletons, we are driven by technological innovation at our core. Our founding team hails from leading universities including Harbin Institute of Technology and Zhejiang University. To date, we hold 165 patents and 174 utility model patents, and have partnered with over 1,700 medical institutions. We are also among the enterprises that help formulate national industry standards for robotic exoskeletons. Our three core product lines consist of medical robotic exoskeletons, industrial robotic exoskeletons, and consumer robotic exoskeletons, serving customers across more than 40 countries and regions worldwide.